The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug ...